Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - KING PHARMACEUTICALS INC | g20793e10vq.htm |
| EX-32.1 - EX-32.1 - KING PHARMACEUTICALS INC | g20793exv32w1.htm |
| EX-31.1 - EX-31.1 - KING PHARMACEUTICALS INC | g20793exv31w1.htm |
| EX-31.2 - EX-31.2 - KING PHARMACEUTICALS INC | g20793exv31w2.htm |
EXHIBIT 32.2
CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with this quarterly report on
Form 10-Q
of King Pharmaceuticals, Inc., I, Carla M. Shumate, Senior Vice
President Finance, Controller of King Pharmaceuticals, Inc.,
certify, pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
1. The report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
2. The information contained in this report fairly
presents, in all material respects, the financial condition and
results of operations of King Pharmaceuticals, Inc.
/s/ CARLA
M. SHUMATE
Carla M. Shumate
Senior Vice President Finance, Controller
Date: November 5, 2009